An 33 year-old woman with a two-year history of hypothyroidism treated with 75 mcg of levothyroxine presented in her 9th week of gestation with fatigue, sweating, palpitations and nervousness.
Physical examination
Diffuse goitre, tachycardia (110 bpm) and distal tremor.
Laboratory tests · TSH <0.04 mU/L (Normal range: 0.34-5 mU/l), free T4 1.66 pg/ml (Normal range: 0.6-1.6 pg/ml). Imaging · Thyroid ultrasound: global enlargement; an 8 mm hyperechoic nodule in the right thyroid lobe.
Evolution
Levothyroxine dose was halved. Two weeks later hyperthyroidism worsened (TSH 0.01 mU/L, free T4 4.22 pg/ml, total T3 3.9 ng/ml). TPO and TSI antibodies were positive. Levothyroxine was stopped and 100 mg/d propylthiouracil (PTU) was started; further doses changes were required. In the third trimester of pregnancy TSH was still supressed, but T3 and free T4 were in the normal range.
Cesarean delivery was performed at 41 weeks. Anti-thyroid treatment was continued and 7,5 mCi radioiodine was given one year after delivery, due to persistent hyperthyroidism. Two months later, the patient developed hypothyroidism, so levothyroxine was resumed. Discussion Conversion of autoimmune hypo-to hyperthyroidism is exceptional during pregnancy. To our knowledge, there are only three cases previously reported.
Although conversion is exceptional on pregnancy, clinical and thyroid function evaluation should be recommended before modification of levothyroxine dose.
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